TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34484562

Group type: EXPERIMENTAL
Intervention: Anthocyanin-rich mulberry milk (2 servings daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anthocyanin-rich mulberry milk (1 serving daily)
Number of subjects: 0
Study: 32478917

Group type: EXPERIMENTAL
Intervention: Long-term abdominal drain
Number of subjects: 36

Group type: COMPARATOR
Intervention: Large-volume paracentesis
Number of subjects: 36
Study: 35930067

Group type: EXPERIMENTAL
Intervention: Lunch
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Supper
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Afternoon snack
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Morning snack
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Lunch fat intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Supper fat intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Lunch protein intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Supper protein intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Breakfast carbohydrate intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Snacks carbohydrate intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Variation in morning snack intake
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Snack intakes with age
Number of subjects: 740
Study: 35680433

Group type: EXPERIMENTAL
Intervention: Deep learning neural network for automated segmentation of L3 CT slices
Number of subjects: 536
Study: 34052593

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB)
Number of subjects: 80
Study: 32673160

Group type: EXPERIMENTAL
Intervention: Supervised exercise training at 65-85% V̇o2peak for 24 weeks, prescribed dose of 8 kcal·kg body wt‐1·wk‐1 (8 KKW) or 20 KKW
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Supervised exercise training at 65-85% V̇o2peak for 24 weeks
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Higher relative perceived exertion
Number of subjects: 110
Study: 35674571

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations (MOPs)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 34020012

Group type: EXPERIMENTAL
Intervention: 70% VO2max exercise
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 35% VO2max exercise
Number of subjects: 210

Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 210
Study: 35244702

Group type: EXPERIMENTAL
Intervention: Immediate APOL1 genetic testing results
Number of subjects: 2050

Group type: COMPARATOR
Intervention: Delayed APOL1 genetic testing results (control)
Number of subjects: 2050
Study: 34074289

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 1.6 × 10^9 CFU for 12 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo capsules for 12 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Calorie-restricted diet
Number of subjects: 44
Study: 36008722

Group type: EXPERIMENTAL
Intervention: Cemiplimab plus chemotherapy (350 mg every 3 weeks for up to 108 weeks)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Cemiplimab plus chemotherapy
Number of subjects: 466
Study: 35109470

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (MediCul score)
Number of subjects: 6236

Group type: EXPERIMENTAL
Intervention: Aerobic physical activity (PA)
Number of subjects: 6236

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 6236

Group type: EXPERIMENTAL
Intervention: Light physical activity
Number of subjects: 6236

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity (MV PA)
Number of subjects: 6236
Study: 33550716

Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP) pretreatment before topical anesthetic cream application
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical anesthetic cream only (control)
Number of subjects: 20
Study: 32054903

Group type: COMPARATOR
Intervention: Bovine lung surfactant applied topically on wounds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 33389549

Group type: EXPERIMENTAL
Intervention: Clazosentan (20 mg/h followed by 60 mg/h continuous infusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clazosentan (simulated 15 mg/h for 3 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33149899

Group type: COMPARATOR
Intervention: Various therapeutic agents tested in adaptive platform trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multi-arm multi-stage (MAMS) trial design
Number of subjects: 0
Study: 35848733

Group type: EXPERIMENTAL
Intervention: Porous and BoneMaster (PBM) coated Exceed cup
Number of subjects: 53

Group type: COMPARATOR
Intervention: Porous-coated (P) Exceed cup
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Normal BMD group
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Osteopenia group
Number of subjects: 53
Study: 34853395

Group type: EXPERIMENTAL
Intervention: High dose vitamin D3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33259247

Group type: EXPERIMENTAL
Intervention: CrossFit (n=16)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Concurrent training (CT) (n=14)
Number of subjects: 30
Study: 35255929

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells (MSCs) plus basiliximab and calcineurin inhibitor
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (without MSCs)
Number of subjects: 203
Study: 33899447

Group type: EXPERIMENTAL
Intervention: Complex spa treatment with transcranial magnetic therapy (TCMT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Identical treatment complex without TCMT (Control)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Complex spa treatment with TCMT
Number of subjects: 122
Study: 34033812

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg daily until delivery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32289352

Group type: EXPERIMENTAL
Intervention: Exercise intervention offered to participants who consented to an observational cohort study.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (cohort only) without exercise intervention.
Number of subjects: 0
Study: 35795916

Group type: EXPERIMENTAL
Intervention: CBT wisdom enhancement timeline technique
Number of subjects: 6
Study: 33321501

Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based intervention (IMI) tailored to CBP plus treatment-as-usual (TAU)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based intervention (IMI)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 210
Study: 33136049

Group type: EXPERIMENTAL
Intervention: Mental-incisive nerve block (MINB) with finger pressure after inferior alveolar nerve block (IANB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group received only standard IANB injection of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 70
Study: 34620759

Group type: EXPERIMENTAL
Intervention: Liquid human milk fortifier (LHMF)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Powder human milk fortifier (PHMF)
Number of subjects: 158
Study: 34959829

Group type: EXPERIMENTAL
Intervention: Vegetable-enriched bread (VB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Commercial white bread (WB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Wheatmeal bread (WMB)
Number of subjects: 10
Study: 32295442

Group type: EXPERIMENTAL
Intervention: Integrative treatment (Western medicine combined with Jianpi Huatan Tongfu granule)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medical treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Integrative treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients with AECOPD
Number of subjects: 60
Study: 36219445

Group type: EXPERIMENTAL
Intervention: Visual messages featuring security forces as messengers
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Visual messages with varying messenger occupations and text content
Number of subjects: 719
Study: 34018381

Group type: EXPERIMENTAL
Intervention: Inhalation aromatherapy with Rosa damascena (5 drops of 40% for 20 minutes)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (inhalation of distilled water)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Inhalation aromatherapy with Rosa damascena
Number of subjects: 98
Study: 33669520

Group type: EXPERIMENTAL
Intervention: RIS-based channel randomization (RCR) technique
Number of subjects: 0
Study: 34656505

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus omega-3 supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 32767049

Group type: EXPERIMENTAL
Intervention: PK radiomics signatures model (PK model) for 2-class classification task
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: PK radiomics signatures model (PK model) for 3-class classification task
Number of subjects: 104
Study: 35358592

Group type: EXPERIMENTAL
Intervention: Bevacizumab (subconjunctival 2.5 mg/0.1 ml at surgery and topical 10 mg/ml 4 times per day for 4 weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 92
Study: 34009444

Group type: EXPERIMENTAL
Intervention: Aktion Glasklar intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32348009

Group type: EXPERIMENTAL
Intervention: iRoot BP Plus (experimental group, n=50)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Calcium hydroxide (control group, n=49)
Number of subjects: 110
Study: 34406466

Group type: EXPERIMENTAL
Intervention: Tri Auto ZX2 with OGP kinematics
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tri Auto ZX2 with continuous rotation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Root ZX II
Number of subjects: 48

Group type: COMPARATOR
Intervention: VDW Gold
Number of subjects: 48
Study: 34229619

Group type: COMPARATOR
Intervention: Telephone therapist delivered cognitive behavioural therapy (TCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Web-based cognitive behavioural therapy (WCBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 32166564

Group type: EXPERIMENTAL
Intervention: T1-ITM (inorganic trace minerals)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: T2-MIX (half ITMs, half CGMs)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: T3-L-CGMs (50% level of T1)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: T4-M-CGMs (70% level of T1)
Number of subjects: 648
Study: 34453878

Group type: EXPERIMENTAL
Intervention: Group-based treatments
Number of subjects: 15
Study: 32092060

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 34588210

Group type: EXPERIMENTAL
Intervention: Discontinued CGM
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Continued CGM
Number of subjects: 163

Group type: COMPARATOR
Intervention: Comparison of Discontinued CGM vs Continued CGM
Number of subjects: 163
Study: 33022653

Group type: EXPERIMENTAL
Intervention: Body weight resistance exercise circuit (CIRC)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Treadmill-based high-intensity interval exercise (TM)
Number of subjects: 17
Study: 35913798

Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids (PUFAs) supplementation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ezetimibe in addition to statins
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs
Number of subjects: 21
Study: 36316798

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cinacalcet (added to eplerenone and amiloride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33635605

Group type: EXPERIMENTAL
Intervention: Resminostat plus S-1
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo plus S-1
Number of subjects: 101
Study: 32298501

Group type: COMPARATOR
Intervention: 100% insulin dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 130% insulin dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 145% insulin dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 160% insulin dose
Number of subjects: 26
Study: 33575961

Group type: EXPERIMENTAL
Intervention: Thymus thymalin (peptide drug)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 32702651

Group type: EXPERIMENTAL
Intervention: Web-based epilepsy education program (WEEP) for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based epilepsy education program (WEEP) for parents
Number of subjects: 0
Study: 33418016

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon Angioplasty (DCB)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Conventional High-Pressure Balloon Angioplasty (HPB)
Number of subjects: 161
Study: 34436635

Group type: COMPARATOR
Intervention: Triathlon PS insert
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Triathlon UC insert
Number of subjects: 120

Group type: COMPARATOR
Intervention: U2 PS insert
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: U2 UC insert
Number of subjects: 120
Study: 34085478

Group type: EXPERIMENTAL
Intervention: Penetrating moxibustion at governor vessel, 2 h per treatment, once a week for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Momethasone furoate nasal spray, 2 sprays per side per time, once a day for 4 weeks
Number of subjects: 90
Study: 33413109

Group type: EXPERIMENTAL
Intervention: Therapist-assisted eHealth intervention
Number of subjects: 188

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 188
Study: 32976501

Group type: EXPERIMENTAL
Intervention: Worms and Ladders board game
Number of subjects: 372

Group type: COMPARATOR
Intervention: Snake and Ladder board game (Control)
Number of subjects: 372
Study: 34907813

Group type: EXPERIMENTAL
Intervention: mavacamten
Number of subjects: 185

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 185
Study: 32141112

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) - 12 sessions of 20 minutes each, energy/session 4.08 J/cm2, thrice/week
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (dietary control and aerobic exercise only)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Non-contact selective-field radiofrequency (NcRF) - four 30-minute treatments once/week
Number of subjects: 54
Study: 36221809

Group type: EXPERIMENTAL
Intervention: Early routine catheter ablation (ER-CA)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Delayed selective catheter ablation (DS-CA)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 102
Study: 33155854

Group type: EXPERIMENTAL
Intervention: Guide sheath (GS) used as an extended working channel (EWC) during TBBx
Number of subjects: 105
Study: 34415819

Group type: EXPERIMENTAL
Intervention: dBTi+wearable group (n = 62)
Number of subjects: 128

Group type: COMPARATOR
Intervention: dBTi group (n = 66)
Number of subjects: 128
Study: 33943030

Group type: EXPERIMENTAL
Intervention: HiCommunication intervention
Number of subjects: 5
Study: 34932853

Group type: EXPERIMENTAL
Intervention: Home phototherapy
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard hospital care
Number of subjects: 147
Study: 34210681

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg Q3W plus ipilimumab 50 mg Q6W for 4 doses (PEM200+IPI50)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg Q3W plus ipilimumab 100 mg Q12W for 4 doses (PEM200+IPI100)
Number of subjects: 102
Study: 32768871

Group type: EXPERIMENTAL
Intervention: Low dietary phosphorus diet (0.18% available phosphorus content)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Full mixed diet (control group)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Metabonomics analysis
Number of subjects: 2
Study: 35129010

Group type: EXPERIMENTAL
Intervention: Gluteal trigger point injection (TP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Epidural steroid injection (ESI)
Number of subjects: 44
Study: 33340443

Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 22500
Study: 35415804

Group type: COMPARATOR
Intervention: Standard arm (30-min didactic intervention)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Enhanced arm (didactic plus weekly messaging and monetary inducement)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Enhanced arm
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 104
Study: 34934054

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg kg-1) acute
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (acute)
Number of subjects: 14
Study: 36108818

Group type: EXPERIMENTAL
Intervention: LHB sparing
Number of subjects: 194

Group type: COMPARATOR
Intervention: LHB sectioning
Number of subjects: 194
Study: 34777214

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sham Dry Needling (SDN)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study: 33524917

Group type: EXPERIMENTAL
Intervention: Radically open dialectical behavior therapy (RO DBT)
Number of subjects: 13
Study: 32956134

Group type: EXPERIMENTAL
Intervention: Physical rehabilitation during the acute hospital stay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical rehabilitation interventions tailored to patient subgroups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interdisciplinary models of service delivery to increase physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical rehabilitation
Number of subjects: 0
Study: 34228856

Group type: EXPERIMENTAL
Intervention: Propofol (Group P)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Desflurane (Group D)
Number of subjects: 59
Study: 32096258

Group type: EXPERIMENTAL
Intervention: Concomitant surgical ablation of atrial fibrillation during CABG and valve surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left atrial appendage closure during AF ablation
Number of subjects: 0
Study: 35695996

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) with usual care
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 149
Study: 32520316

Group type: EXPERIMENTAL
Intervention: 16% THC flower
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 24% THC flower
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 70% THC concentrate
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 90% THC concentrate
Number of subjects: 121

Group type: COMPARATOR
Intervention: Concentrate users vs Flower users
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Short-term cannabis consumption
Number of subjects: 121
Study: 34613575

Group type: EXPERIMENTAL
Intervention: Triple antithrombotic therapy (TAT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Dual antithrombotic therapy (DAT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Matched cohort of TAT
Number of subjects: 83

Group type: COMPARATOR
Intervention: Matched cohort of DAT
Number of subjects: 83
Study: 33963873

Group type: EXPERIMENTAL
Intervention: UPLIFT (telephone-based depression self-management program)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study: 35137493

Group type: EXPERIMENTAL
Intervention: Intranasal naloxone (1.4 mg/0.1 mL)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Intramuscular naloxone (0.8 mg/2 mL)
Number of subjects: 201
Study: 33257495

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Using Prolonged Exposure - Adolescent (COPE-A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Person-Centred Therapy (PCT)
Number of subjects: 100
Study: 35123427

Group type: EXPERIMENTAL
Intervention: rTMS combined with CBT
Number of subjects: 132

Group type: COMPARATOR
Intervention: Next pharmacological step (switch to tricyclic antidepressant or augmentation with lithium or second-generation antipsychotic) combined with CBT
Number of subjects: 132
Study: 33607029

Group type: EXPERIMENTAL
Intervention: Household finished flooring
Number of subjects: 7795
Study: 32481305

Group type: EXPERIMENTAL
Intervention: Shenfu Qiangxin Pills (SFQX)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 35546412

Group type: EXPERIMENTAL
Intervention: Customized app with individual feedback regarding self-reported medication intake for 12 months
Number of subjects: 960

Group type: COMPARATOR
Intervention: Customized app without individual feedback regarding self-reported medication intake for 12 months
Number of subjects: 960
Study: 32804212

Group type: EXPERIMENTAL
Intervention: MATCH
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 206
Study: 33026243

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg, 15 mg pooled)
Number of subjects: 8246
Study: 33397319

Group type: EXPERIMENTAL
Intervention: Communication-related early stimulation behaviors (ESB)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Physical intimate partner violence (IPV)
Number of subjects: 374